HomeBCLI • NASDAQ
add
Brainstorm Cell Therapeutics Inc
Previous close
$2.02
Day range
$2.05 - $2.05
Year range
$1.05 - $11.89
Market cap
11.69M USD
Avg Volume
111.86K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.05M | -49.49% |
Net income | -2.71M | -120.88% |
Net profit margin | — | — |
Earnings per share | -0.51 | 75.56% |
EBITDA | -2.99M | 49.93% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 168.00K | -88.15% |
Total assets | 2.02M | -64.36% |
Total liabilities | 8.08M | -2.20% |
Total equity | -6.06M | — |
Shares outstanding | 5.70M | — |
Price to book | -1.77 | — |
Return on assets | -197.72% | — |
Return on capital | 195.86% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -2.71M | -120.88% |
Cash from operations | -3.30M | 48.53% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -3.30M | -588.02% |
Free cash flow | -2.16M | 48.64% |
About
Founded
2000
Website
Employees
29
